Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Oral BG-12 in multiple sclerosis.
Neuromodulation of lower limb motor control in restorative neurology.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Managing MS: Trends, Issues, and Perspectives.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Generation of oligodendroglial cells by direct lineage conversion.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.

Pages